This policy ensures that patients can confidently explore their treatment options, knowing they will not incur unnecessary costs if LIPO-C therapy is not deemed suitable for their needs
Note: Ozempic , Mounjaro , and metformin are not FDA-approved to treat obesity or for weight loss
But some plans offer out-of-network prescription benefits that may provide partial reimbursement
The disadvantage is that it depends entirely on individual gut health starting conditions, dietary habits, and microbiome composition, all of which vary dramatically between people
Phase I, driven by the cytochrome P450 enzyme family, breaks down fat-soluble toxins via oxidation, reduction, and hydrolysis